Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11601
Pulmonx
LUNG
$88M
| $100K | ﹤0.01% |
45,257
-171,919
| -79% | -$323K |
|
11602
PUT
Vaalco Energy
EGY
$552M
| $99.7K | ﹤0.01% |
27,400
-21,300
| -44% | -$78.8K |
|
|
CMRC
11603
CALL
Commerce.com Inc Series 1
CMRC
$191M
| $99.7K | ﹤0.01% |
+24,200
| New | +$112K |
|
11604
Lantern Pharma
LTRN
$35.5M
| $99.7K | ﹤0.01% |
+32,895
| New | +$122K |
|
|
ATYR
11605
CALL
aTyr Pharma
ATYR
$49.2M
| $99.6K | ﹤0.01% |
127,200
-72,600
| -36% | -$59.6K |
|
|
WTF
11606
Waton Financial Ltd
WTF
$144M
| $99.6K | ﹤0.01% |
+30,167
| New | +$135K |
|
11607
CALL
Spruce Power Holding Corp
SPRU
$42.2M
| $99.3K | ﹤0.01% |
19,500
-4,700
| -19% | -$19.1K |
|
11608
Blue Ridge Bankshares
BRBS
$331M
| $99.1K | ﹤0.01% |
23,215
-83,259
| -78% | -$361K |
|
|
CRCG
11609
PUT
Leverage Shares 2X Long CRCL Daily ETF
CRCG
$84.9M
| $99.1K | ﹤0.01% |
3,810
+1,600
| +72% | +$87.4K |
|
11610
CALL
Star Holdings Shares of Beneficial Interest
STHO
$115M
| $98.8K | ﹤0.01% |
12,000
-1,500
| -11% | -$11.5K |
|
|
OBE
11611
PUT
Obsidian Energy
OBE
$640M
| $98.7K | ﹤0.01% |
+16,100
| New | +$97.4K |
|
11612
PUT
SES AI
SES
$187M
| $98.1K | ﹤0.01% |
54,500
-65,500
| -55% | -$147K |
|
|
HYFT
11613
PUT
MindWalk Holdings
HYFT
$60.1M
| $98.1K | ﹤0.01% |
+53,900
| New | +$94.9K |
|
11614
PUT
Lexicon Pharmaceuticals
LXRX
$1.05B
| $98.1K | ﹤0.01% |
85,300
-11,300
| -12% | -$15.5K |
|
|
NA
11615
CALL
Nano Labs
NA
$42.5M
| $98K | ﹤0.01% |
31,100
-29,400
| -49% | -$126K |
|
|
RWT
11616
CALL
Redwood Trust
RWT
$573M
| $97.9K | ﹤0.01% |
17,700
-18,800
| -52% | -$103K |
|
11617
Bridgeline Digital
BLIN
$13.6M
| $97.8K | ﹤0.01% |
117,838
+86,769
| +279% | +$99.3K |
|
11618
CALL
Atlas Lithium Corp
ATLX
$87.6M
| $97.7K | ﹤0.01% |
23,100
-40,600
| -64% | -$205K |
|
11619
Evogene
EVGN
$8.29M
| $97.6K | ﹤0.01% |
88,764
+31,189
| +54% | +$36.4K |
|
|
MEME
11620
PUT
Roundhill Meme Stock ETF
MEME
$13.6M
| $97.3K | ﹤0.01% |
+15,700
| New | +$119K |
|
11621
PUT
Comtech Telecommunications
CMTL
$51.5M
| $97.3K | ﹤0.01% |
18,400
+5,300
| +40% | +$17.3K |
|
11622
PUT
Ambev
ABEV
$46.5B
| $97.3K | ﹤0.01% |
39,400
-900
| -2% | -$2.14K |
|
|
RDNW
11623
CALL
RideNow Group
RDNW
$264M
| $97.2K | ﹤0.01% |
17,600
-23,900
| -58% | -$112K |
|
11624
CALL
NRX Pharmaceuticals
NRXP
$132M
| $97K | ﹤0.01% |
35,800
+2,900
| +9% | +$7.78K |
|
11625
NexGel
NXGL
$3.13M
| $97K | ﹤0.01% |
60,230
+32,776
| +119% | +$67.7K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.